Oaktree Acquisition Corp. III Life Sciences Class A (OACC)
NASDAQ:OACC
Total Valuation
Oaktree Acquisition Corp. III Life Sciences Class A has a market cap or net worth of $259.59M. The enterprise value is $258.17M.
Market Cap$259.59M
Enterprise Value$258.17M
Share Statistics
Oaktree Acquisition Corp. III Life Sciences Class A has 19,783,010 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding19,783,010
Owned by Insiders―
Owned by Institutions58.40%
Financial Efficiency
Oaktree Acquisition Corp. III Life Sciences Class A’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -0.59%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)-0.59%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee0.00
Profits Per Employee2.43M
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Oaktree Acquisition Corp. III Life Sciences Class A is 27.9. Oaktree Acquisition Corp. III Life Sciences Class A’s PEG ratio is 0.06.
PE Ratio27.9
PS Ratio0.00
PB Ratio1.04
Price to Fair Value1.04
Price to FCF-481.25
Price to Operating Cash Flow-933.11
PEG Ratio0.06
Income Statement
In the last 12 months, Oaktree Acquisition Corp. III Life Sciences Class A had revenue of 0.00 and earned 7.29M in profits. Earnings per share was 0.30.
Revenue0.00
Gross Profit0.00
Operating Income-1.20M
Pretax Income7.29M
Net Income7.29M
EBITDA-1.20M
Earnings Per Share (EPS)0.30
Cash Flow
In the last 12 months, operating cash flow was -278.20K and capital expenditures 0.00, giving a free cash flow of -278.20K billion.
Operating Cash Flow-278.20K
Free Cash Flow-278.20K
Free Cash Flow per Share-0.01
Dividends & Yields
Oaktree Acquisition Corp. III Life Sciences Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.05
52-Week Price Change3.94%
50-Day Moving Average10.64
200-Day Moving Average10.55
Relative Strength Index (RSI)42.36
Average Volume (3m)63.92K
Important Dates
Oaktree Acquisition Corp. III Life Sciences Class A upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Oaktree Acquisition Corp. III Life Sciences Class A as a current ratio of 1.19, with Debt / Equity ratio of <0.01%
Current Ratio1.19
Quick Ratio1.19
Debt to Market Cap<0.01
Net Debt to EBITDA1.19
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Oaktree Acquisition Corp. III Life Sciences Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Oaktree Acquisition Corp. III Life Sciences Class A EV to EBITDA ratio is -168.69, with an EV/FCF ratio of -477.88.
EV to Sales0.00
EV to EBITDA-168.69
EV to Free Cash Flow-477.88
EV to Operating Cash Flow-477.88
Balance Sheet
Oaktree Acquisition Corp. III Life Sciences Class A has $1.33M in cash and marketable securities with $11.82K in debt, giving a net cash position of $1.32M billion.
Cash & Marketable Securities$1.33M
Total Debt$11.82K
Net Cash$1.32M
Net Cash Per Share$0.07
Tangible Book Value Per Share$10.15
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Oaktree Acquisition Corp. III Life Sciences Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―